Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 125
Single User License Price INR 8431
Corporate User License Price USD 375
Corporate User License Price INR 25294
Site License Price USD 250
Site License Price INR 16863
Request a Quote

Report Title

ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review

Quote Request for License Type
License Type Price  
Single User License USD 125
Site License USD 250
Enterprise Wide License USD 375
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review


Quote Request for License Type
License Type Price  
Single User License USD 125
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

ImmuCell Corporation ICCC-Financial and Strategic SWOT Analysis Review



Executive Summary

ImmuCell Corporation (ICCC)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ImmuCell Corporation (Immucell) is an animal health biotechnology company. It develops, manufactures and markets products that improve animal health and productivity in the dairy and beef industries. The company focuses on the prevention, diagnosis and treatment of bovine diseases. The company's major products include First Defense bovine coronavirus-escherichia coli antibody; Wipe Out dairy wipes; and California Mastitis Test (CMT). Immucell is also developing Mast Out, an intramammary infusion product for the treatment of subclinical mastitis in lactating dairy cows. The company has developed its products based on the requirement in two areas, namely, Intelligent Mastitis Management and Calf Health. The company sells its products through distributors and dairy producers. ImmuCell is headquartered in Maine, the US.

ImmuCell Corporation Key Recent Developments

May 11, 2016: ImmuCell Announces First Quarter 2016 Financial Results

Feb 10, 2016: ImmuCell Announces Full Year 2015 Financial Results

Jan 28, 2016: ImmuCell Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results

Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015

Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

ImmuCell Corporation-Key Facts 6

ImmuCell Corporation-Key Employees 7

ImmuCell Corporation-Key Employee Biographies 8

ImmuCell Corporation-Key Operational Employees 9

ImmuCell Corporation-Major Products and Services 10

ImmuCell Corporation-History 11

ImmuCell Corporation-Locations And Subsidiaries 13

Head Office 13

Section 2-Company Analysis 14

ImmuCell Corporation-Business Description 14

ImmuCell Corporation-Corporate Strategy 15

ImmuCell Corporation-SWOT Analysis 16

SWOT Analysis-Overview 16

ImmuCell Corporation-Strengths 16

Strength-Flagship Product First Defense 16

Strength-Distribution Network 16

Strength-Robust Technical and Corporate Expertise 16

ImmuCell Corporation-Weaknesses 17

Weakness-Dependence on Single Product 17

ImmuCell Corporation-Opportunities 18

Opportunity-Growth Potential: Mastitis 18

Opportunity-Veterinary Market 18

Opportunity-Strategic Initiatives 18

ImmuCell Corporation-Threats 19

Threat-Stiff Competition 19

Threat-Bovine Diseases 19

Threat-Stringent Regulations 19

ImmuCell Corporation-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 24

Financial Performance 24

Financial Ratios-Interim Ratios 25

Financial Ratios-Ratio Charts 26

Section 4-Company's Lifesciences Financial Deals and Alliances 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

ImmuCell Corporation, Recent Deals Summary 29

Section 5-Company's Recent Developments 30

Nov 12, 2015: ImmuCell Announces Results for Third Quarter of 2015 30

Aug 13, 2015: ImmuCell Announces Results for Second Quarter of 2015 32

May 12, 2015: ImmuCell Announces Results for First Quarter of 2015 34

Section 6-Appendix 36

Methodology 36

Ratio Definitions 36

About GlobalData 40

Contact Us 40

Disclaimer 40

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

ImmuCell Corporation, Performance Chart (2011-2015) 24

ImmuCell Corporation, Ratio Charts 26

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 28

List of Tables

ImmuCell Corporation, Key Facts 6

ImmuCell Corporation, Key Employees 7

ImmuCell Corporation, Key Employee Biographies 8

ImmuCell Corporation, Key Operational Employees 9

ImmuCell Corporation, Major Products and Services 10

ImmuCell Corporation, History 11

ImmuCell Corporation, Key Competitors 20

ImmuCell Corporation, Ratios based on current share price 21

ImmuCell Corporation, Annual Ratios 22

ImmuCell Corporation, Interim Ratios 25

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 27

ImmuCell Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 28

ImmuCell Corporation, Recent Deals Summary 29

Currency Codes 36

Capital Market Ratios 36

Equity Ratios 37

Profitability Ratios 37

Cost Ratios 38

Liquidity Ratios 38

Leverage Ratios 39

Efficiency Ratios 39

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Zoetis Inc.

MSD Animal Health Nederland

Idexx Laboratories, Inc.

Elanco Animal Health, Inc.

Boehringer Ingelheim Animal Health Gmbh

ImmuCell Corporation, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand